[go: up one dir, main page]

NO952119L - Benzopyrone analogues for the treatment of anxiety, mania, depression or withdrawal symptoms - Google Patents

Benzopyrone analogues for the treatment of anxiety, mania, depression or withdrawal symptoms

Info

Publication number
NO952119L
NO952119L NO952119A NO952119A NO952119L NO 952119 L NO952119 L NO 952119L NO 952119 A NO952119 A NO 952119A NO 952119 A NO952119 A NO 952119A NO 952119 L NO952119 L NO 952119L
Authority
NO
Norway
Prior art keywords
benzopyrone
mania
anxiety
analogues
depression
Prior art date
Application number
NO952119A
Other languages
Norwegian (no)
Other versions
NO315733B1 (en
NO952119D0 (en
Inventor
John Morris Evans
Mervyn Thompson
Neil Upton
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO952119D0 publication Critical patent/NO952119D0/en
Publication of NO952119L publication Critical patent/NO952119L/en
Publication of NO315733B1 publication Critical patent/NO315733B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19952119A 1992-11-30 1995-05-29 Benzopyrone analogues, their use and pharmaceutical preparations containing them NO315733B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB1992/002222 WO1994012173A1 (en) 1992-11-30 1992-11-30 Benzopyron analogues for the treatment of anxiety, mania, depression or withdrawal symptoms

Publications (3)

Publication Number Publication Date
NO952119D0 NO952119D0 (en) 1995-05-29
NO952119L true NO952119L (en) 1995-05-29
NO315733B1 NO315733B1 (en) 2003-10-20

Family

ID=10709714

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19952119A NO315733B1 (en) 1992-11-30 1995-05-29 Benzopyrone analogues, their use and pharmaceutical preparations containing them

Country Status (5)

Country Link
CZ (1) CZ282172B6 (en)
FI (1) FI952609L (en)
NO (1) NO315733B1 (en)
SK (1) SK281507B6 (en)
WO (1) WO1994012173A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5574049A (en) * 1994-07-22 1996-11-12 Sandoz Ltd. 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans
US6298535B1 (en) 2000-02-16 2001-10-09 William Ross Lower Wheel lifting rod assembly
DE10348298A1 (en) * 2003-10-17 2005-05-19 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 2- (4-sulfonylamino) -3-hydroxy-3,4-dihydro-2H-chromen-6-ylderivade, processes and intermediates for their preparation, and medicaments containing these compounds
BRPI0519013A2 (en) 2004-12-13 2009-11-03 Lilly Co Eli single compound or stereoisomers, mixtures of pharmaceutically acceptable stereoisomers, salts, tautomers or prodrugs thereof, pharmaceutical composition, and use of a compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3479726D1 (en) * 1983-05-18 1989-10-19 Beecham Group Plc BENZOPYRAN DERIVATIVES.
US4632939A (en) * 1985-03-15 1986-12-30 Eli Lilly And Company Anticonvulsant agents
PH22522A (en) * 1985-09-03 1988-10-17 Ciba Geigy Ag 3-amino-dihydro-1-benzopyrans and benzothiopyrans, their pharmaceutical compositions and method of using said compounds
US5021432A (en) * 1988-04-26 1991-06-04 Yoshitomi Pharmaceutical Industries, Ltd. Benzopyran compound and its pharmaceutical use

Also Published As

Publication number Publication date
NO315733B1 (en) 2003-10-20
WO1994012173A1 (en) 1994-06-09
CZ282172B6 (en) 1997-05-14
NO952119D0 (en) 1995-05-29
FI952609L (en) 1995-05-30
FI952609A0 (en) 1995-05-29
CZ139095A3 (en) 1996-01-17
SK281507B6 (en) 2001-04-09
SK70995A3 (en) 1995-11-08

Similar Documents

Publication Publication Date Title
IT1213514B (en) PROCEDURE AND DEVICE FOR THE PURIFICATION OF REJECT GAS.
FR2615394B1 (en) USE OF CERTAIN 17-CETOSTEROIDS, POSSIBLY WITH AN IMMUNOMODULATOR AND / OR ANTIVIRAL AGENT, TO MANUFACTURE A MEDICAMENT FOR THE TREATMENT AND PREVENTION OF RETROVIRAL INFECTIONS
FI96942B (en) Silica sols, process for making silica soles and the use of sols
FI871750L (en) NASAL ADMINISTRATION AV LAEKEMEDEL.
IT1115552B (en) PROCEDURE FOR THE SELECTIVE ELIMINATION OF LIPOPROTEINS FROM PLASMA OR BLOOD SERUM
FI890305A0 (en) FOERFARANDE FOER INDIKERING AV BASISKT CEILINGS ELLER DRUGS.
NO904696D0 (en) ELECTROSTATIC, LIQUID EMERGENCY AND PROCEDURE FOR THE MANUFACTURING OF THIS.
NO885254D0 (en) ELECTROSTATIC, LIQUID EMERGENCY AND PROCEDURE FOR THE MANUFACTURING OF THEM.
FI871923L (en) ANVAENDNING AV POLYMERA BAERARMASSOR VID BIOCHEMISKA OMVANDLINGSPROCESSER I VATTENFAS.
FI903008A0 (en) ELEKTRISK FJAERRSTYRNINGSANORDNING SOM AER ANALOG ELLER AV KOPPLINGSTYP.
FI893937L (en) NEW ANTI-ARRHYTHMIC DRUGS OF THE 2nd GENERA.
NO895334L (en) ELECTROSTATIC, LIQUID EMERGENCY AND PROCEDURE FOR THE MANUFACTURING OF THIS.
ITMI922799A0 (en) PROCEDURE FOR THE SEPARATION OF HF FROM ITS MIXTURES WITH HYDROCHLOROFLUOCARBONS 123 AND/OR 124
NO952119D0 (en) Benzopyrone analogues for the treatment of anxiety, mania, depression or withdrawal symptoms
FI854425A0 (en) ANORDINATION FOR THE PASSAGERING OF THE PASSAGER RULES ELLER LIKNANDE, SPECIELLT I BUSSAR.
FI894368L (en) RECOMBINATIONSSYSTEM FOER EXPRESSION AV EN CHOLERA B-UNDERENHET MED HJAELP AV FRAEMMANDE PROMOTORER OCH/ELLER HUVUDPEPTIDER.
MX163757B (en) SPRINKLER WITH INDUCED AIR SUPPORT
IT8848638A0 (en) SILICON-CONTAINING PEPTIDES, THEIR PREPARATION AND THEIR USE AS MEDICINES
NO893890L (en) PROCEDURE FOR THE REMOVAL OF SULPHIDS.
PT86137A (en) DEVICE FOR THE CRIOPRECIPITATION OF BLOOD PLASMA
BR9207178A (en) Benzopyron analogues for the treatment of anxiety symptoms, depression or withdrawal
FR2601592B1 (en) NON-FLAMMABLE AIR FRESHENER
IS3382A7 (en) Spray (touch) condenser that works at normal atmospheric pressure
HU9501563D0 (en) Benzopyron analogues for the treatment of anxiety, mania, depression or withdrawal symptoms
FI891940A0 (en) FOERFARANDE VID EFTERBEHANDLING AV PAPPER ELLER KARTONG.